Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Aerie Pharmaceuticals Inc.
DescriptionSecond generation rho kinase/norepinephrine inhibitor
Molecular Target Rho kinase ; Norepinephrine transporter
Mechanism of ActionRho kinase inhibitor; Norepinephrine transporter (NET) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationGlaucoma
Indication DetailsTreat glaucoma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today